Similar articles

• Alkylating agents as leukemogens in multiple myeloma.

  Karchmer RK, Amare M, Larsen WE, Mallouk AG, Caldwell GG. Karchmer RK, et al. Cancer. 1974 Apr;33(4):1103-7. doi: 10.1002/1097-0142(197404)33:4<1103::aid-cncr2820330432>3.0.co;2-s. Cancer. 1974. PMID: 4522494 No abstract available.
• [Acute granulous leukemia in multiple myeloma. Apropos of 5 cases].

  Krulik M, Grolleau JY, Audebert AA, Mougeot-Martin M, Harousseau JL, Hervouet D, Debray J. Krulik M, et al. Sem Hop. 1977 Dec 9;53(42):2425-35. Sem Hop. 1977. PMID: 203043 Review. French.
• [Myeloma, melphalan and acute myelo-monocytic leukemia. Apropos of a case].

  Cywiner-Golenzer C, Adotti F, Marsan C, Quillard A, Henon P, Grimaldi A, Dryll A. Cywiner-Golenzer C, et al. Sem Hop. 1974 Jan 14;50(3):207-11. Sem Hop. 1974. PMID: 4367926 French. No abstract available.
• A case of multiple myeloma terminating with acute myelomonocytic leukemia after long-term melphalan therapy.

  Ota H, Ikeda Y, Shibata T, Hirabayashi N. Ota H, et al. Nihon Ketsueki Gakkai Zasshi. 1974 Feb;37(1):49-57. Nihon Ketsueki Gakkai Zasshi. 1974. PMID: 4526861 No abstract available.
• Acute leukemia following prolonged cytotoxic agent therapy.

  Casciato DA, Scott JL. Casciato DA, et al. Medicine (Baltimore). 1979 Jan;58(1):32-47. doi: 10.1097/00005792-197901000-00002. Medicine (Baltimore). 1979. PMID: 105227 Review.